Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | DGKA | P23743 | 2/20 | 0.41 |
| ▸ | PRKCA | P17252 | 3/20 | 0.40 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.40 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.40 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL421820 | 1.00 | MGLL (0.45) | MGLLEPHX2DGKAPRKCAPRKCE | |
| SCHEMBL19133947 | 0.99 | MGLL (0.46) | MGLLEPHX2DGKAPRKCAPRKCE | |
| SCHEMBL441410 | 0.99 | MGLL (0.46) | MGLLEPHX2DGKAPRKCAPRKCE | |
| Hydrochloric Acid SCHEMBL421819 | 0.87 | MGLL (0.46) | MGLLEPHX2DGKAPRKCAPRKCE | |
| Hydrochloric Acid SCHEMBL4074680 | 0.87 | MGLL (0.46) | MGLLEPHX2DGKAPRKCAPRKCE | |
| Water SCHEMBL6549696 | 0.85 | MGLL (0.46) | MGLLEPHX2DGKAPRKCAPRKCE | |
| Hydrochloric Acid SCHEMBL18209371 | 0.81 | DGKA (0.47) | MGLLEPHX2DGKAPRKCACNR2 | |
| Hydrochloric Acid SCHEMBL888280 | 0.81 | DGKA (0.47) | MGLLEPHX2DGKAPRKCACNR2 | |
| Hydrochloric Acid SCHEMBL25292894 | 0.80 | MGLL (0.43) | MGLLEPHX2DGKAPRKCAPRKCE | |
| Hydrochloric Acid SCHEMBL6706588 | 0.80 | MGLL (0.43) | MGLLEPHX2DGKAPRKCAPRKCE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2763657-B1 | MOLECULE MIXTURE COMPRISING AN AMPHIPATHIC MOLECULE TYPE A, WHICH HAS A POSITIVE TOTAL CHARGE IN THE HYDROPHILIC RANGE, AND AN AMPHIPATHIC MOLECULE TYPE B AND A POLYPHENOL C, METHOD FOR PRODUCING SAID MOLECULE MIXTURE AND USE THEREOF | FORSCHUNGSZENTRUM JUELICH GMBH (DE) | 2020-03-25 | — | — | EP | claimed |
| US-20250277267-A1 | TECHNIQUE FOR DIAGNOSING AND MONITORING NEURODEGENERATIVE DISEASES ON BASIS OF BODY FLUID ANALYSIS | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2025-09-04 | — | — | US | disclosed |
| EP-4334333-A1 | CHIMERIC IMMUNOGENS AND METHODS FOR MAKING POLYCLONAL ANTIBODIES AGAINST SPECIFIC EPITOPES | Agilent Technologies, Inc. (US) | 2024-03-13 | — | — | EP | disclosed |
| CN-117597109-A | Single use of polymer vesicle-associated adjuvants for stimulating immune responses | ACM 生物实验室私人有限公司 | 2024-02-23 | — | — | CN | disclosed |
| US-20240002934-A1 | COMPOSITION FOR DETECTING TARGET NUCLEIC ACID AND METHOD FOR DETECTING TARGET NUCLEIC ACID USING SAME | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2024-01-04 | — | — | US | disclosed |
| CN-117222656-A | Chimeric immunogens and methods for preparing polyclonal antibodies directed against specific epitopes | 安捷伦科技有限公司 | 2023-12-12 | — | — | CN | disclosed |
| CN-112040941-A | In situ method of inducing an immune response | 阿托莎医疗公司 | 2020-12-04 | — | — | CN | disclosed |
| CN-111936152-A | Method for intraductal treatment of mammary disorders | 阿托莎医疗公司 | 2020-11-13 | — | — | CN | disclosed |
| EP-3700564-A1 | IMMUNOSTIMULATORY COMPOSITIONS | Bayer Animal Health GmbH (DE) | 2020-09-02 | — | — | EP | disclosed |
| WO-2019115385-A1 | IMMUNOSTIMULATORY COMPOSITIONS | BAYER ANIMAL HEALTH GMBH (DE) | 2019-06-20 | — | — | WO | disclosed |
| WO-2012132022-A9 | AGENT FOR PROMOTING GENE TRANSFER AND METHOD OF GENE TRANSFER USING THE SAME | FUKUOKA PREFECTURAL GOVERNMENT (JP) | 2015-01-15 | — | — | WO | disclosed |
| US-20130058994-A1 | LIPOSOMES CONTAINING OLIGOPEPTIDE FRAGMENTS OF MYELIN BASIC PROTEIN, A PHARMACEUTICAL COMPOSITION AND A METHOD FOR TREATMENT OF MULTIPLE SCLEROSIS | LIPOXEN TECHNOLOGIES LIMITED (GB) | 2013-03-07 | — | — | US | disclosed |
| WO-2012132022-A1 | AGENT FOR PROMOTING GENE TRANSFER AND METHOD OF GENE TRANSFER USING THE SAME | FUKUOKA PREFECTURAL GOVERNMENT (JP) | 2012-10-04 | — | — | WO | disclosed |
| US-7709457-B2 | treating bladder cancer; transfecting with polynucleotide into urothelial cells; improved transfection efficiency with cationic lipids, cationic polymers or dendrimers; improve drug delivery with a solubilized cholesterol | GENECURE PTE LTD. (SG) | 2010-05-04 | — | — | US | disclosed |
| US-20090054364-A1 | treating bladder cancer; transfecting with polynucleotide into urothelial cells; improved transfection efficiency with cationic lipids, cationic polymers or dendrimers; improve drug delivery with a solubilized cholesterol | GENECURE PTE LTD. | 2009-02-26 | — | — | US | disclosed |
| US-7320963-B2 | Transfecting polynucleotide into cells; obtain transfection mixture, incubate with solublize in cholesterol mixture, expose with cells, recover transfected cells | GENECURE PTE LTD (SG) | 2008-01-22 | — | — | US | disclosed |
| EP-1208218-B1 | METHODS AND COMPOSITIONS FOR DELIVERY OF PHARMACEUTICAL AGENTS | GENECURE PTE LTD (SG) | 2005-03-30 | — | — | EP | disclosed |
| US-20020146830-A1 | Transfecting polynucleotide into cells; obtain transfection mixture, incubate with solublize in cholesterol mixture, expose with cells, recover transfected cells | GENECURE PTE LTD (SG) | 2002-10-10 | — | — | US | disclosed |
| EP-1208218-A2 | METHODS AND COMPOSITIONS FOR DELIVERY OF PHARMACEUTICAL AGENTS | Genecure Pte Ltd (SG) | 2002-05-29 | — | — | EP | disclosed |
| WO-2001015755-A2 | METHODS AND COMPOSITIONS FOR DELIVERY OF PHARMACEUTICAL AGENTS | GENECURE PTE LTD (SG) | 2001-03-08 | — | — | WO | disclosed |